Next Article in Journal
Bacterium-like Particles from Corynebacterium pseudodiphtheriticum as Mucosal Adjuvant for the Development of Pneumococcal Vaccines
Previous Article in Journal
Design and Characterization of a New Formulation for the Delivery of COVID-19-mRNA Vaccine to the Nasal Mucosa
Previous Article in Special Issue
Efficacy of HPV Vaccination Regarding Vulvar and Vaginal Recurrences in Previously Treated Women: The Need for Further Evidence
 
 
Article

Article Versions Notes

Vaccines 2024, 12(4), 411; https://doi.org/10.3390/vaccines12040411
Action Date Notes Link
article xml file uploaded 12 April 2024 15:21 CEST Original file -
article xml uploaded. 12 April 2024 15:21 CEST Update -
article pdf uploaded. 12 April 2024 15:21 CEST Version of Record -
article html file updated 12 April 2024 15:22 CEST Original file -
article xml file uploaded 12 April 2024 15:25 CEST Update -
article xml uploaded. 12 April 2024 15:25 CEST Update https://www.mdpi.com/2076-393X/12/4/411/xml
article pdf uploaded. 12 April 2024 15:25 CEST Updated version of record https://www.mdpi.com/2076-393X/12/4/411/pdf
article html file updated 12 April 2024 15:27 CEST Update https://www.mdpi.com/2076-393X/12/4/411/html
Back to TopTop